BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 20567899)

  • 1. Possible risk modifications in the association between MnSOD Ala-9Val polymorphism and breast cancer risk: subgroup analysis and evidence-based sample size calculation for a future trial.
    Chen Y; Pei J
    Breast Cancer Res Treat; 2011 Jan; 125(2):495-504. PubMed ID: 20567899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of association between MnSOD Val16Ala polymorphism and breast cancer risk: a meta-analysis involving 58,448 subjects.
    Qiu LX; Yao L; Mao C; Chen B; Zhan P; Yuan H; Xue K; Zhang J; Hu XC
    Breast Cancer Res Treat; 2010 Sep; 123(2):543-7. PubMed ID: 20143154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic polymorphism of manganese superoxide dismutase (MnSOD) and breast cancer susceptibility.
    Kocabaş NA; Sardaş S; Cholerton S; Daly AK; Elhan AH; Karakaya AE
    Cell Biochem Funct; 2005; 23(1):73-6. PubMed ID: 15386537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between polymorphism in the manganese superoxide dismutase gene and breast cancer.
    Eras-Erdogan N; Akbas E; Senli H; Kul S; Colak T
    Mutat Res; 2009; 680(1-2):7-11. PubMed ID: 19712751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between manganese superoxide dismutase gene polymorphism and breast cancer risk: a meta-analysis of 17,842 subjects.
    Liu G; Sun G; Wang Y; Wang D; Hu W; Zhang J
    Mol Med Rep; 2012 Oct; 6(4):797-804. PubMed ID: 22825700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between manganese superoxide dismutase (MnSOD) Val-9Ala polymorphism and cancer risk - A meta-analysis.
    Wang S; Wang F; Shi X; Dai J; Peng Y; Guo X; Wang X; Shen H; Hu Z
    Eur J Cancer; 2009 Nov; 45(16):2874-81. PubMed ID: 19467856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Manganese superoxide dismutase (MnSOD) genetic polymorphism is associated with risk of early-onset prostate cancer.
    Arsova-Sarafinovska Z; Matevska N; Petrovski D; Banev S; Dzikova S; Georgiev V; Sikole A; Sayal A; Aydin A; Suturkova L; Dimovski AJ
    Cell Biochem Funct; 2008 Oct; 26(7):771-7. PubMed ID: 18646267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Manganese superoxide dismutase Ala-9Val polymorphism, environmental modifiers, and risk of breast cancer in a German population.
    Slanger TE; Chang-Claude J; Wang-Gohrke S
    Cancer Causes Control; 2006 Oct; 17(8):1025-31. PubMed ID: 16933053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Target sequence polymorphism of human manganese superoxide dismutase gene and its association with cancer risk: a review.
    Bag A; Bag N
    Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3298-305. PubMed ID: 19064542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Manganese superoxide dismutase (MnSOD) genetic polymorphisms, dietary antioxidants, and risk of breast cancer.
    Ambrosone CB; Freudenheim JL; Thompson PA; Bowman E; Vena JE; Marshall JR; Graham S; Laughlin R; Nemoto T; Shields PG
    Cancer Res; 1999 Feb; 59(3):602-6. PubMed ID: 9973207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MnSOD polymorphisms in sensitized patients with delayed-type hypersensitivity reactions to the chemical allergen para-phenylene diamine: a case-control study.
    Brans R; Dickel H; Bruckner T; Coenraads PJ; Heesen M; Merk HF; Blömeke B
    Toxicology; 2005 Sep; 212(2-3):148-54. PubMed ID: 15951095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk: a meta-analysis from 41 studies with 16,480 cases and 22,388 controls.
    Qi X; Ma X; Yang X; Fan L; Zhang Y; Zhang F; Chen L; Zhou Y; Jiang J
    Breast Cancer Res Treat; 2010 Sep; 123(2):499-506. PubMed ID: 20135343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic polymorphism in the manganese superoxide dismutase gene is associated with an increased risk for hepatocellular carcinoma in HCV-infected Moroccan patients.
    Ezzikouri S; El Feydi AE; Chafik A; Afifi R; El Kihal L; Benazzouz M; Hassar M; Pineau P; Benjelloun S
    Mutat Res; 2008 Jan; 649(1-2):1-6. PubMed ID: 18023606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Manganese superoxide dismutase polymorphism, plasma antioxidants, cigarette smoking, and risk of breast cancer.
    Tamimi RM; Hankinson SE; Spiegelman D; Colditz GA; Hunter DJ
    Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):989-96. PubMed ID: 15184255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Functional polymorphism of manganese superoxide dismutase (MnSOD) gene correlates with schizophrenia in Polish population].
    Gałecki P; Pietras T; Szemraj J; Florkowska K; Florkowski A; Zboralski K
    Pol Merkur Lekarski; 2006 Mar; 20(117):329-32. PubMed ID: 16780268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors influencing the association between CYP17 T34C polymorphism and the risk of breast cancer: meta-regression and subgroup analysis.
    Chen Y; Pei J
    Breast Cancer Res Treat; 2010 Jul; 122(2):471-81. PubMed ID: 20043206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGFB1 T29C polymorphism and breast cancer risk: a meta-analysis based on 10,417 cases and 11,455 controls.
    Gu D; Zhuang L; Huang H; Cao P; Wang D; Tang J; Chen J
    Breast Cancer Res Treat; 2010 Oct; 123(3):857-61. PubMed ID: 20157775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of two polymorphisms of the manganese superoxide dismutase gene (Ile-58Thr and Ala-9Val) in patients with recurrent depressive disorder.
    Gałecki P; Smigielski J; Florkowski A; Bobińska K; Pietras T; Szemraj J
    Psychiatry Res; 2010 Aug; 179(1):43-6. PubMed ID: 20478627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRCA2 N372H polymorphism and breast cancer susceptibility: a meta-analysis involving 44,903 subjects.
    Qiu LX; Yao L; Xue K; Zhang J; Mao C; Chen B; Zhan P; Yuan H; Hu XC
    Breast Cancer Res Treat; 2010 Sep; 123(2):487-90. PubMed ID: 20135345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of an association between a functional polymorphism in the interleukin-6 gene promoter and breast cancer risk: a meta-analysis involving 25,703 subjects.
    Yu KD; Di GH; Fan L; Chen AX; Yang C; Shao ZM
    Breast Cancer Res Treat; 2010 Jul; 122(2):483-8. PubMed ID: 20043205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.